Krane Funds Advisors LLC Dr Reddys Laboratories LTD Transaction History

Krane Funds Advisors LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2019 Aug 13, 2019	SELL	$36.05 - $42.76 $77,074 - $91,420	-2,138 Closed	0 $0
Q1 2019 May 06, 2019	SELL	$35.77 - $40.57 $78,372 - $88,888	-2,191 Reduced 50.61%	2,138 $0
Q4 2018 Feb 14, 2019	SELL	$31.89 - $38.44 $39,479 - $47,588	-1,238 Reduced 22.24%	4,329 $411,000
Q3 2018 Nov 19, 2018	BUY	$29.25 - $36.73 $25,272 - $31,734	864 Added 18.37%	5,567 $420,000
Q2 2018 Aug 13, 2018	BUY	$28.49 - $35.06 $119,401 - $146,936	4,191 Added 818.55%	4,703 $329,000
Q1 2018 May 15, 2018	BUY	$31.93 - $39.54 $16,348 - $20,244	512 New	512 $17,000

233

24M

14.6K

2.8K

Ticker RDY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 166,028,992
Market Cap $13.2B
Description
Dr. Reddy's Laboratories Limited, together with its subsidiaries, operates as an integrated pharmaceutical company worldwide. It operates through Global Generics, Pharmaceutical Services and Active Ingredients (PSAI), Proprietary Products, and Others segments. The company's Global Generics segment manufactures and markets prescription and over-t...

Get notified when there are updates to the investment portfolio of Krane Funds Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Krane Funds Advisors LLC with notifications on news.